Enochian Biosciences (ENOB) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 112 252 sessions, October 4, 2022 to October 4, 2023
- Largest daily move
- +82.4% close of August 9, 2023
- 1-year change
- +140.9% closing prices, October 4, 2022 to October 4, 2023
- 5-year change
- -20.5% closing prices, October 4, 2018 to October 4, 2023
Company Description
Enochian Biosciences (Nasdaq: ENOB) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $44.6M.
ENOB has gained 140.9% over the past year. The last closing price was $4.65.
This page collects what Stock Titan holds for ENOB, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Enochian Biosciences (ENOB) closed at $4.65 on October 4, 2023. Over the past 12 months, the price has gained 140.9%.
ENOB Metrics & Rankings
Price returns through October 4, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Enochian Biosciences has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval. View all ENOB news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ENOB Company Profile & Sector Positioning
Enochian Biosciences (ENOB) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing ENOB often look at related companies in the same sector, including Verrica Pharmaceuticals Inc. (VRCA), Outlook Therapeutics, Inc. (OTLK), PLUS THERAPEUTICS, Inc. (PSTV), Annovis Bio, Inc. (ANVS), and Telomir Pharmaceuticals, Inc. (TELO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ENOB's relative position within its industry.